Skip to main content
. 2016 Jul 1;95(26):e4049. doi: 10.1097/MD.0000000000004049

Figure 3.

Figure 3

Kaplan–Meier cumulative event rates of the primary end points according to drug-eluting stent generation and the presence of CYP2C19 loss-of-function alleles. (A) The first-generation drug-eluting stents group among patients with stable angina; (B) the newer-generation drug-eluting stents group among patients with stable angina; (C) the first-generation drug-eluting stents group among patients with AMI; (D) the newer-generation drug-eluting stents group among patients with AMI. AMI = acute myocardial infarction, MACCE = major adverse cardiac and cerebrovascular event.